ICU Medical, Inc. IC7.F Stock
ICU Medical, Inc. Price Chart
ICU Medical, Inc. IC7.F Financial and Trading Overview
ICU Medical, Inc. stock price | 96 EUR |
Previous Close | 170 EUR |
Open | 170 EUR |
Bid | 170 EUR x 6200 |
Ask | 176 EUR x 6100 |
Day's Range | 170 - 170 EUR |
52 Week Range | 136 - 189 EUR |
Volume | 10 EUR |
Avg. Volume | 0 EUR |
Market Cap | 4.09B EUR |
Beta (5Y Monthly) | 0.62676 |
PE Ratio (TTM) | N/A |
EPS (TTM) | -2.25 EUR |
Forward Dividend & Yield | N/A (N/A) |
Ex-Dividend Date | N/A |
1y Target Est | 296 EUR |
IC7.F Valuation Measures
Enterprise Value | 5.79B EUR |
Trailing P/E | N/A |
Forward P/E | 21.935484 |
PEG Ratio (5 yr expected) | 1.81 |
Price/Sales (ttm) | 1.7744114 |
Price/Book (mrq) | 1.9476652 |
Enterprise Value/Revenue | 2.511 |
Enterprise Value/EBITDA | 22.082 |
Trading Information
ICU Medical, Inc. Stock Price History
Beta (5Y Monthly) | 0.62676 |
52-Week Change | 16.99% |
S&P500 52-Week Change | 20.43% |
52 Week High | 189 EUR |
52 Week Low | 136 EUR |
50-Day Moving Average | 165.08 EUR |
200-Day Moving Average | 157.3 EUR |
IC7.F Share Statistics
Avg. Volume (3 month) | 0 EUR |
Avg. Daily Volume (10-Days) | 0 EUR |
Shares Outstanding | 24.06M |
Float | 20.13M |
Short Ratio | N/A |
% Held by Insiders | 16.26% |
% Held by Institutions | 94.35% |
Shares Short | N/A |
Short % of Float | N/A |
Short % of Shares Outstanding | N/A |
Dividends & Splits
Trailing Annual Dividend Rate | 0 |
Trailing Annual Dividend Yield | 0% |
5 Year Average Dividend Yield | N/A |
Payout Ratio | 0 |
Last Split Factor |
Financial Highlights
Fiscal Year
Fiscal Year Ends | December 31, 2022 |
Most Recent Quarter (mrq) | March 31, 2023 |
Next Fiscal Year End | December 31, 2023 |
Profitability
Profit Margin | -1.99% |
Operating Margin (ttm) | 1.05% |
Gross Margin | 31.27% |
EBITDA Margin | 11.37% |
Management Effectiveness
Return on Assets (ttm) | 0.33% |
Return on Equity (ttm) | -2.15% |
Income Statement
Revenue (ttm) | 2.31B EUR |
Revenue Per Share (ttm) | 96.22 EUR |
Quarterly Revenue Growth (yoy) | 4.70% |
Gross Profit (ttm) | 697.76M EUR |
EBITDA | 262.15M EUR |
Net Income Avi to Common (ttm) | -46030000 EUR |
Diluted EPS (ttm) | -1.79 |
Quarterly Earnings Growth (yoy) | N/A |
Balance Sheet
Total Cash (mrq) | 251M EUR |
Total Cash Per Share (mrq) | 10.43 EUR |
Total Debt (mrq) | 1.73B EUR |
Total Debt/Equity (mrq) | 82.48 EUR |
Current Ratio (mrq) | 2.625 |
Book Value Per Share (mrq) | 87.284 |
Cash Flow Statement
Operating Cash Flow (ttm) | -19542000 EUR |
Levered Free Cash Flow (ttm) | -33384376 EUR |
Profile of ICU Medical, Inc.
Country | Germany |
State | CA |
City | San Clemente |
Address | 951 Calle Amanecer |
ZIP | 92673 |
Phone | 949 366 2183 |
Website | https://www.icumed.com |
Industry | Medical Instruments & Supplies |
Sector(s) | Healthcare |
Full Time Employees | 14500 |
ICU Medical, Inc., together with its subsidiaries, develops, manufactures, and sells medical devices used in infusion therapy, vascular access, and vital care applications worldwide. Its infusion therapy products include needlefree products under the MicroClave, MicroClave Clear, and NanoClave brands; Neutron catheter patency devices; ChemoClave and ChemoLock closed system transfer devices, which are used to limit the escape of hazardous drugs or vapor concentrations, block the transfer of environmental contaminants into the system, and eliminates the risk of needlestick injury; and ClearGuard HD, that maintains hemodialysis catheters. The company provides IV therapy and diluents, such as sodium chloride, dextrose, balanced electrolyte solutions, lactated ringer's, ringer's, mannitol, sodium chloride/dextrose, and sterile water; and irrigation solutions comprising sodium chloride and sterile water irrigation, physiologic solutions, ringer's irrigation, acetic acid irrigation, glycine irrigation, sorbitol-mannitol irrigation, flexible containers, and pour bottle options. It offers infusion pumps under the Plum 360 brand; IV mediation safety software, including ICU Medical MedNet, an enterprise-class medication management platform that connects smart pumps to hospital's electronic health records, asset tracking systems, and alarm notification platforms; professional services; critical care products, such as Cogent 2-in-1 and CardioFlo hemodynamic monitoring systems; TDQ and OptiQ cardiac output monitoring catheters; TriOx venous oximetry catheters; Transpac blood pressure transducers; and SafeSet closed blood sampling and conservation systems. The company's customers include acute care hospitals, wholesalers, ambulatory clinics, and alternate site facilities, including outpatient clinics, home health care providers, and long-term care facilities. ICU Medical, Inc. was founded in 1984 and is headquartered in San Clemente, California.
Q&A For ICU Medical, Inc. Stock
What is a current IC7.F stock price?
ICU Medical, Inc. IC7.F stock price today per share is 96 EUR.
How to purchase ICU Medical, Inc. stock?
You can buy IC7.F shares on the Frankfurt exchange. Contact your financial advisor to select a broker.
What is the ticker symbol for ICU Medical, Inc.?
The stock symbol or ticker of ICU Medical, Inc. is IC7.F.
Which industry does the ICU Medical, Inc. company belong to?
The ICU Medical, Inc. industry is Medical Instruments & Supplies.
How many shares does ICU Medical, Inc. have in circulation?
The max supply of ICU Medical, Inc. shares is 25.17M.
What is ICU Medical, Inc. Price to Earnings Ratio (PE Ratio)?
ICU Medical, Inc. PE Ratio is now.
What was ICU Medical, Inc. earnings per share over the trailing 12 months (TTM)?
ICU Medical, Inc. EPS is -2.25 EUR over the trailing 12 months.
Which sector does the ICU Medical, Inc. company belong to?
The ICU Medical, Inc. sector is Healthcare.